NCT01985984 Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy
| NCT ID | NCT01985984 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maastricht Radiation Oncology |
| Condition | Head and Neck Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2012-07 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2012-07 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary and general objective of the clinical introduction of the Standard Follow-up Program (SFP) as the current standard of care is to improve the quality of radiotherapy for head and neck cancer patients by reducing radiation-induced side effects without hampering treatment efficacy in terms of locoregional tumour control and overall survival and to systematically evaluate the beneficial effect of newly introduced radiation technology for this particular group of patients. The clinical introduction of the SFP will allow for a systematic and broad scale quality improvement cycle for head and neck cancer patients treated with radiotherapy. In fact, this methodology can be considered a kind of quality circle for the clinical introduction of new radiation techniques, aiming at continuous efforts for further improvement.
Eligibility Criteria
Inclusion Criteria: All patients planned for curatively intended primary or postoperative radiotherapy Exclusion Criteria: All patients planned for palliative radiotherapy
Contact & Investigator
F Hoebers, MD, PhD
PRINCIPAL INVESTIGATOR
Maastro Clinic, The Netherlands
Frequently Asked Questions
Who can join the NCT01985984 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01985984 currently recruiting?
Yes, NCT01985984 is actively recruiting participants. Contact the research team at frank.hoebers@maastro.nl for enrollment information.
Where is the NCT01985984 trial being conducted?
This trial is being conducted at Maastricht, Netherlands.
Who is sponsoring the NCT01985984 clinical trial?
NCT01985984 is sponsored by Maastricht Radiation Oncology. The principal investigator is F Hoebers, MD, PhD at Maastro Clinic, The Netherlands. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.